Colorectal Cancer Screening: What's New and Why
Expires: 09/30/2023 (subject to change)
- CE for this activity will not be available after this date.
Colorectal cancer (CRC) is the second deadliest form of cancer, behind only lung cancer. In 2022, about 151,000 adults will be diagnosed with CRC, and about 52,600 people will die from CRC. Early detection of CRC is critical to reducing cancer-related mortality. Because of the increasing incidence and mortality of CRC in young adults, major US medical societies have recently moved to recommend earlier CRC screening in average-risk adults, starting at 45 years of age. Provider education and training efforts are needed to encourage the various colorectal cancer screening options and adopting a shared decision-making approach during discussions about colorectal cancer screening.
- Evaluate recent changes in CRC screening guidelines and their potential impact on early cancer detection and patient outcomes.
- Explain the rationale for guideline recommendations to include patients in the CRC screening decision-making process.
- Individualize discussion of CRC screening options according to patient goals.
Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
This program was planned in accordance with AANP CE Standards and Policies.
- Speaker Bureau:
- Sanofi-Pasteur, Merck, Pfizer: Vaccines Sanofi-Pasteur, Merck, Pfizer, Moderna, and Seqirus: VaccinesGlaxoSmithKline: OA and PainBayer: Chronic Kidney DiseaseIdorsia: InsomniaShield Therapeutics: Iron Deficiency Anemia
- AbbVie and Biohaven: Migraines
- Idorsia: Insomnia
- Sanofi-Pasteur, Merck, Pfizer, Moderna, and Seqirus: Vaccines
- GlaxoSmithKline: OA and Pain
- Bayer: Chronic Kidney Disease
- Idorsia: Insomnia
- Shield Therapeutics: Iron Deficiency Anemia
All Planners involved in this activity have no relevant financial relationships to disclose.
Planners: Michele L. McKay, MSN, APRN, FNP-C, CHCP (AANP Education Specialist)Supported by an unrestricted educational grant from Exact Sciences Corporation
Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete the Pretest associated to the activity.
- Complete the educational content:
- Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
- Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
- After completing all content, click on the blue Next Steps button:
- Complete the post-test.
- Submit the evaluation to receive full AANP CE/Rx credit.
For questions or more information concerning this online CE opportunity contact the AANP CE Center Manager at CECenter@aanp.org.
Additional CE activities of interest
What the Evidence Tells Us About Effective Alternative to Opioid Therapies and How to Effectively Manage Patients Participating in Buprenorphine or Methadone Recovery Programs
Safe Opioid Prescribing Using National Standards in Primary Care
Understanding Pain Medication Pharmacology, Abuse-Deterrent Formulations, and When and How to Use Them
Pain Management: 2022 and Beyond